Distal Hereditary Motor Neuropathy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Distal hereditary motor neuropathy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Distal Hereditary Motor Neuropathy Today - Breaking & Trending Today

Live by the SORD: Applied Therapeutics looks to rare disease NDA

Based on positive phase III study data, Applied Therapeutics Inc. plans to take its CNS-penetrant aldose reductase inhibitor to the U.S. FDA to talk about an NDA for treating the rare disease sorbitol dehydrogenase (SORD) deficiency. SORD, a hereditary axonal neuropathy created by sorbitol dehydrogenase gene mutations, affects about 3,300 people in the U.S. and about 4,000 in Europe, according to Applied Therapeutics. ....

Therapeutics Inc , Applied Therapeutics , Applied Therapeutics Inc , At 007 , Sorbitol Dehydrogenase Deficiency , Rare Disease , Neurology Psychiatric , Charcot Marie Tooth Disease , Distal Hereditary Motor Neuropathy ,